(Q50990392)

26 March 2018

title

Validation of an immunohistochemical signature predictive of 8-year outcome for patients with breast carcinoma. (English)

1 reference

26 March 2018

1 reference

7

Daniel Birnbaum

1 reference

26 March 2018

author name string

Colette Charpin

1

1 reference

26 March 2018

Fattaneh Tavassoli

2

1 reference

26 March 2018

Véronique Secq

3

1 reference

26 March 2018

Sophie Giusiano

4

1 reference

26 March 2018

Julia Villeret

5

1 reference

26 March 2018

Stéphane Garcia

6

1 reference

26 March 2018

Pascal Bonnier

8

1 reference

26 March 2018

Marie-Noëlle Lavaut

9

1 reference

26 March 2018

Léon Boubli

10

1 reference

26 March 2018

Xavier Carcopino

11

1 reference

26 March 2018

Juan Iovanna

12

1 reference

26 March 2018

language of work or name

English

0 references

publication date

3 January 2012

1 reference

26 March 2018

International Journal of Cancer

published in

1 reference

26 March 2018

volume

131

1 reference

26 March 2018

issue

3

1 reference

26 March 2018

page(s)

E236-43

1 reference

26 March 2018

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

cites work

1 reference

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

21 January 2018

1 reference

Molecular portraits of human breast tumours

21 January 2018

1 reference

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes

21 January 2018

1 reference

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

21 January 2018

1 reference

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

Gene expression profiling: does it add predictive accuracy to clinical characteristics in cancer prognosis?

21 January 2018

1 reference

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification

21 January 2018

1 reference

Automated subcellular localization and quantification of protein expression in tissue microarrays.

21 January 2018

1 reference

Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its impl

21 January 2018

1 reference

Antibody validation by quantitative analysis of protein expression using expression of Met in breast cancer as a model

21 January 2018

1 reference

A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays

21 January 2018

1 reference

Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma

21 January 2018

1 reference

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

Gene expression profiling of breast cell lines identifies potential new basal markers.

21 January 2018

1 reference

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

Moesin expression is a marker of basal breast carcinomas.

21 January 2018

1 reference

Demystifying basal-like breast carcinomas

21 January 2018

1 reference

Triple negative tumours: a critical review

21 January 2018

1 reference

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

21 January 2018

1 reference

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

21 January 2018

1 reference

Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro

21 January 2018

1 reference

Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents

21 January 2018

1 reference

Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer

21 January 2018

1 reference

Hypoxia signalling in cancer and approaches to enforce tumour regression

21 January 2018

1 reference

Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905).

21 January 2018

1 reference

Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer

21 January 2018

1 reference

HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.

21 January 2018

1 reference

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27371

1 reference

26 March 2018

PubMed ID

22120430

1 reference

26 March 2018